Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism

Author:

Saiki Aya1,Otsuki Michio1ORCID,Tamada Daisuke1,Kitamura Tetsuhiro1,Shimomura Iichiro1,Kurihara Isao2,Ichijo Takamasa3,Takeda Yoshiyu4,Katabami Takuyuki5,Tsuiki Mika6,Wada Norio7,Yanase Toshihiko8,Ogawa Yoshihiro9,Kawashima Junji10,Sone Masakatsu11,Inagaki Nobuya11ORCID,Yoshimoto Takanobu1213,Okamoto Ryuji14ORCID,Takahashi Katsutoshi15,Kobayashi Hiroki16,Tamura Kouichi17ORCID,Kamemura Kohei18,Yamamoto Koichi19,Izawa Shoichiro20,Kakutani Miki21,Yamada Masanobu22,Tanabe Akiyo23,Naruse Mitsuhide624

Affiliation:

1. Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

2. Department of Endocrinology, Metabolism, and Nephrology, School of Medicine, Keio University, Tokyo, Japan

3. Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan

4. Department of Internal Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

5. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan

6. Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

7. Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan

8. Muta Hospital, Fukuoka, Japan

9. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

10. Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

11. Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan

12. Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan

13. Department of Diabetes and Endocrinology, Tokyo Metropolitan Hiroo Hospital Tokyo, Tokyo, Japan

14. Department of Cardiology, Mie University Hospital, Mie, Japan

15. Division of Metabolism, Showa General Hospital, Tokyo, Japan

16. Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan

17. Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan

18. Department of Cardiology, Shinko Hospital, Kobe, Japan

19. Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

20. Department of Endocrinology and Metabolism, Tottori University Hospital, Yonago, Japan

21. Division of Diabetes, Endocrinology, and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan

22. Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan

23. Division of Endocrinology, National Center for Global Health and Medicine, Tokyo, Japan

24. Endocrine Center, Ijinkai Takeda General Hospital, Kyoto, Japan

Abstract

Abstract Context The prevalence of diabetes mellitus (DM) in patients with primary aldosteronism (PA) is higher than in those with essential hypertension and the general population. Although DM is a common major risk factor for cardio-cerebrovascular (CCV) diseases and renal complications, details of its effects in PA have not been demonstrated. Objective The aim of this study was to determine the effects of coexistent DM on the risk of CCV events and progression of renal complications in PA patients. Design A multi-institutional, cross-sectional study was conducted. Patients and Methods PA patients experienced between January 2006 and October 2016 and with available data of CCV events and DM were enrolled from the Japan PA registry of the Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study (n = 2524). CCV events and renal complications were compared between a DM group and a non-DM group by logistic and liner-regression analysis. Results DM significantly increased the odds ratio (OR) of CCV events (OR 1.59, 95% CI: 1.05-2.41) and that of proteinuria (OR 2.25, 95% CI: 1.59-3.16). DM correlated significantly with declines in estimated glomerular filtration rate (β = .05, P = .02). Conclusions This the first report to demonstrate the presence of DM as an independent risk factor for CCV events and renal complications, even in PA patients. Management of DM should be considered in addition to the specific treatment of PA.

Funder

Japan Agency for Medical Research and Development

National Center for Global Health and Medicine

Ministry of Health, Labour and Welfare

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3